1. Home
  2. PERI vs SLN Comparison

PERI vs SLN Comparison

Compare PERI & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PERI
  • SLN
  • Stock Information
  • Founded
  • PERI 1999
  • SLN 1994
  • Country
  • PERI Israel
  • SLN United Kingdom
  • Employees
  • PERI N/A
  • SLN N/A
  • Industry
  • PERI EDP Services
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • PERI Technology
  • SLN Health Care
  • Exchange
  • PERI Nasdaq
  • SLN Nasdaq
  • Market Cap
  • PERI 430.0M
  • SLN 352.2M
  • IPO Year
  • PERI 2006
  • SLN N/A
  • Fundamental
  • Price
  • PERI $8.52
  • SLN $6.50
  • Analyst Decision
  • PERI Hold
  • SLN Strong Buy
  • Analyst Count
  • PERI 5
  • SLN 4
  • Target Price
  • PERI $10.17
  • SLN $61.50
  • AVG Volume (30 Days)
  • PERI 265.9K
  • SLN 959.2K
  • Earning Date
  • PERI 02-05-2025
  • SLN 11-14-2024
  • Dividend Yield
  • PERI N/A
  • SLN N/A
  • EPS Growth
  • PERI N/A
  • SLN N/A
  • EPS
  • PERI 0.93
  • SLN N/A
  • Revenue
  • PERI $602,939,000.00
  • SLN $21,773,221.00
  • Revenue This Year
  • PERI N/A
  • SLN N/A
  • Revenue Next Year
  • PERI N/A
  • SLN $104.98
  • P/E Ratio
  • PERI $9.25
  • SLN N/A
  • Revenue Growth
  • PERI N/A
  • SLN N/A
  • 52 Week Low
  • PERI $7.47
  • SLN $5.81
  • 52 Week High
  • PERI $31.60
  • SLN $27.72
  • Technical
  • Relative Strength Index (RSI)
  • PERI 46.91
  • SLN 27.00
  • Support Level
  • PERI $8.48
  • SLN $6.16
  • Resistance Level
  • PERI $9.09
  • SLN $8.88
  • Average True Range (ATR)
  • PERI 0.28
  • SLN 0.69
  • MACD
  • PERI -0.06
  • SLN 0.21
  • Stochastic Oscillator
  • PERI 18.75
  • SLN 22.35

About PERI Perion Network Ltd.

Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

Share on Social Networks: